Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 17, 2009

Endothelial Lipase Gene Mutations Result in High Levels of HDL-C

  • Mutations in the endothelial lipase gene (LIPG) result in high plasma HDL-C levels, according to scientists at the University of Pennsylvania. They determined that the increased plasma HDL-C levels are created because the mutations in LIPG cause loss of endothelial lipase activity.

    Therefore inhibition of endothelial lipase is likely to raise HDL-C levels in humans, the researchers suggest. They caution, however, that further study is required to find out whether the resulting increase would impact cardiovascular health.

    The authors examined LIPG in 585 subjects of European ancestry and identified 10 people with previously unreported rare mutated forms of this gene that were unique to subjects with very high HDL-C levels.

    The article appeared online March 16 in the Journal of Clinical Investigation.

Related content


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »